Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2003 2
2007 1
2008 2
2009 2
2011 1
2015 1
2016 1
2017 2
2018 3
2020 5
2021 4
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Congenital cutaneous lymphadenoma.
Fernandez-Flores A, Nicklaus-Wollenteit I, Sathishkumar D, Diba V, Richard B, Carr R, Moss C, Nagy A, Ogboli M, Colmenero I. Fernandez-Flores A, et al. Among authors: ogboli m. J Cutan Pathol. 2017 Nov;44(11):954-957. doi: 10.1111/cup.13016. Epub 2017 Sep 5. J Cutan Pathol. 2017. PMID: 28796320
Cartilage hair hypoplasia with cutaneous lymphomatoid granulomatosis.
Sathishkumar D, Gach JE, Ogboli M, Desai M, Cole T, Högler W, Motwani J, Norton A, Morland B, Colmenero I. Sathishkumar D, et al. Among authors: ogboli m. Clin Exp Dermatol. 2018 Aug;43(6):713-717. doi: 10.1111/ced.13543. Epub 2018 May 10. Clin Exp Dermatol. 2018. PMID: 29744913
Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition.
Burleigh A, Moraitis E, Al Masroori E, Al-Abadi E, Hong Y, Omoyinmi E, Titheradge H, Stals K, Jones WD, Gait A, Jayarajan V, Di WL, Sebire N, Solman L, Ogboli M, Welch SB, Sudarsanam A, Wacogne I, Price-Kuehne F, Jensen B, Brogan PA, Eleftheriou D. Burleigh A, et al. Among authors: ogboli m. Front Immunol. 2023 Dec 5;14:1287258. doi: 10.3389/fimmu.2023.1287258. eCollection 2023. Front Immunol. 2023. PMID: 38115997 Free PMC article.
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
Thomas KS, Batchelor JM, Akram P, Chalmers JR, Haines RH, Meakin GD, Duley L, Ravenscroft JC, Rogers A, Sach TH, Santer M, Tan W, White J, Whitton ME, Williams HC, Cheung ST, Hamad H, Wright A, Ingram JR, Levell NJ, Goulding JMR, Makrygeorgou A, Bewley A, Ogboli M, Stainforth J, Ferguson A, Laguda B, Wahie S, Ellis R, Azad J, Rajasekaran A, Eleftheriadou V, Montgomery AA; UK Dermatology Clinical Trials Network’s HI-Light Vitiligo Trial Team. Thomas KS, et al. Among authors: ogboli m. Br J Dermatol. 2021 May;184(5):828-839. doi: 10.1111/bjd.19592. Epub 2020 Dec 28. Br J Dermatol. 2021. PMID: 33006767 Clinical Trial.
26 results